| mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-07 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.0001 |